middle.news

Resonance Health funds three growth bets after a profitable FY26

12:45pm on Thursday 19th of November, 2026 AEDT • Healthcare
Read Story

Resonance Health funds three growth bets after a profitable FY26

12:45pm on Thursday 19th of November, 2026 AEDT
Key Points
  • FY26 revenue rose 42% to $15.8 million
  • Net profit reached $1.5 million after a $1.7 million loss
  • Oversubscribed $6 million placement funded obesity endpoints, TrialsWest expansion and fibrosis-device development
  • FY27 guidance is $17 million to $22 million revenue and $2.6 million to $3.6 million normalised EBITDA
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Resonance Health (ASX:RHT)
OPEN ARTICLE